Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Cyclosporine/PUVA approach to psoriasis raises cancer risk
Boston - Use of the immunosuppressant cyclosporine on patientswith psoriasis who have had substantial psoralen and ultra violet A lighttreatments show a sevenfold increase in the number of squamous cell cancertumors, according to Robert S. Stern, M.D.
Recent Videos
Related Content
